CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results. (Q47123396)

From Wikidata

Jump to navigation Jump to search

scientific article published on 21 September 2017

Language	Label	Description	Also known as
English	CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results.	scientific article published on 21 September 2017

Statements

scholarly article

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results. (English)

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

23

object named as

Sara Mostafavi

1 reference

Europe PubMed Central

8 January 2018

Stephanie J. Lee

12

object named as

Stephanie J Lee

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Steven Z. Pavletic

24

object named as

Steven Pavletic

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

author name string

Amina Kariminia

1

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Sabine Ivison

2

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Bernard Ng

3

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Jacob Rozmus

4

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Susanna Sung

5

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Avani Varshney

6

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Mahmoud Aljurf

7

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Sylvie Lachance

8

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Irwin Walker

9

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Cindy Toze

10

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Jeff Lipton

11

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Jeff Szer

13

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Richard Doocey

14

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Ian Lewis

15

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Clayton Smith

16

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Naeem Chaudhri

17

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Megan K Levings

18

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Raewyn Broady

19

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Gerald Devins

20

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

David Szwajcer

21

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Ronan Foley

22

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Donna A Wall

25

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Stephan Couban

26

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Tony Panzarella

27

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Kirk R Schultz

28

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

language of work or name

1 reference

based on heuristic

inferred from title

publication date

21 September 2017

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

102

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

1936-1946

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

11

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Comparison of Patient-Reported Outcomes in 5-Year Survivors Who Received Bone Marrow vs Peripheral Blood Unrelated Donor Transplantation: Long-term Follow-up of a Randomized Clinical Trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Selective Depletion of αβ T Cells and B Cells for Human Leukocyte Antigen-Haploidentical Hematopoietic Stem Cell Transplantation. A Three-Year Follow-Up of Procedure Efficiency

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Marrow grafts from HLA-identical siblings for severe aplastic anemia: does limiting the number of transplanted marrow cells reduce the risk of chronic GvHD?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Group 3 innate lymphoid cells in tissue damage and graft-versus-host disease pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Recovery of Unrelated Donors of Peripheral Blood Stem Cells versus Recovery of Unrelated Donors of Bone Marrow: A Prespecified Analysis from the Phase III Blood and Marrow Transplant Clinical Trials Network Protocol 0201

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Granulocyte Colony-Stimulating Factor-Mobilized Allografts Contain Activated Immune Cell Subsets Associated with Risk of Acute and Chronic Graft-versus-Host Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

T-bet is critical for the development of acute graft-versus-host disease through controlling T cell differentiation and function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Multi-institutional study of post-transplantation cyclophosphamide as single-agent graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation using myeloablative busulfan and fludarabine conditioning

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

The complex and central role of interferon-γ in graft-versus-host disease and graft-versus-tumor activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Do Natural T Regulatory Cells become Activated to Antigen Specific T Regulatory Cells in Transplantation and in Autoimmunity?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Peripheral-blood stem cells versus bone marrow from unrelated donors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

The Th1 life cycle: molecular control of IFN-γ to IL-10 switching

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Dichotomous role of interferon-gamma in allogeneic bone marrow transplant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Peripheral blood grafts from unrelated donors are associated with increased acute and chronic graft-versus-host disease without improved survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Dendritic cells in allogeneic hematopoietic stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

1994 Consensus Conference on Acute GVHD Grading

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

Acute and chronic graft-versus-host disease in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

23 May 2018

The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

15 August 2018

Post-Transplant Cyclophosphamide and Tacrolimus-Mycophenolate Mofetil Combination Prevents Graft-versus-Host Disease in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

15 August 2018

Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

15 August 2018

The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

15 August 2018

Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

15 August 2018

Unrelated donor peripheral blood stem cell transplants incorporating pre-transplant in-vivo alemtuzumab are not associated with any increased risk of significant acute or chronic graft-versus-host disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

15 August 2018

Comparative analysis of naïve and memory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

15 August 2018

Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

15 August 2018

Acute graft-versus-host disease and steroid treatment impair CD11c+ and CD123+ dendritic cell reconstitution after allogeneic peripheral blood stem cell transplantation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

15 August 2018

Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia: a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

1 December 2018

Differential responses to interleukin 2 define functionally distinct subsets of human natural killer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5664398

1 December 2018

Altered Toll-Like Receptor 9 Responses in Circulating B Cells at the Onset of Extensive Chronic Graft-versus-Host Disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of Allogeneic Peripheral Blood Stem Cell Transplantation by Donor Graft CD3+/Tregs Ratio: A Single-Center Experience

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantati

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peripheral blood stem cells for allografting

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Low incidence of chronic GVHD after HLA-haploidentical peripheral blood stem cell transplantation with post-transplantation cyclophosphamide in older patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of granulocyte colony-stimulating factor on marrow- and blood-derived hematopoietic and immune cell populations in healthy human donors

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplants

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recipient interferon-gamma 3/3 genotype contributes to the development of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Higher doses of CD34+ peripheral blood stem cells are associated with increased mortality from chronic graft-versus-host disease after allogeneic HLA-identical sibling transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/28935847

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2017.170928

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

release_r6mfhxi7tffybdhh4iq6pkzw3u

1 reference

https://api.fatcat.wiki/v0/release/r6mfhxi7tffybdhh4iq6pkzw3u

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

1 reference

Europe PubMed Central

8 January 2018

http://europepmc.org/abstract/PMC/5664398

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47123396&oldid=2081282090"